SLRX vs ULTA · $4.9M cap vs P/E 17, rev $3.04B
Salarius Pharmaceuticals Inc (SLRX) versus Ulta Beauty Inc (ULTA) — a side-by-side from cached financials, not a winner call.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Ulta Beauty Inc (ULTA) is a specialty retail company listed on NASDAQ.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
Latest reported ULTA revenue for 2026-08-01 was $3.04B. Net income was $282.0M. Revenue was down 4.1% from 2026-05-02 to 2026-08-01. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
SLRX currently screens at market cap $4.9M. ULTA currently screens at market cap $19.38B and trailing P/E 16.9.
Not investment advice. Open the SLRX and ULTA stock pages for the full models.
Not investment advice.